Micro Computed Tomography Market (2026 - 2033)

Micro Computed Tomography Market Summary

The global micro computed tomography market size was valued at USD 312.8 million in 2025 and is projected to grow from USD 339.3 million in 2026 to USD 611.7 million by 2033, at a CAGR of 8.8% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 46.4% in 2025. The market is growing steadily, driven by rising demand for high-resolution, non-destructive 3D imaging across biomedical, materials, energy, and pharmaceutical research.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

Key Market Trends & Insights

• By product: Laboratory / Benchtop Micro-CT segment dominated the market, with a revenue share of 52.2% in 2025.
• By technology: Spatial resolution segment held the largest market share of 34.6% in 2025.
• By application: Biomedical & preclinical research segment held the largest revenue share of 36.0% in 2025.
• By end use: Research institutes segment accounted for the largest revenue share of 38.4% in 2025.

Regional Highlights

• Largest regional market: North America (46.4% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
• By country: The U.S. held the largest market share in 2025.

Market Size & Forecast

• Market size in 2025: USD 312.8 Million
• Estimated market size in 2026: USD 339.3 Million
• Projected market size by 2033: USD 611.7 Million
• CAGR (2026-2033): 8.8%

Other drivers include expanding preclinical and translational research, growing use of micro-CT for battery and advanced-materials characterization, and advances in detector technology, X-ray sources, and software. Integration of AI-assisted reconstruction and analysis is further improving image quality, scan speed, and throughput, making micro-CT more accessible to a wider range of laboratories.

To learn more about this report, Download Free Sample Report

Micro computed tomography (micro-CT) is a high-resolution X-ray imaging technique that produces detailed three-dimensional images of internal structures at micron and sub-micron scale without destroying the sample. It is widely used to study bone microarchitecture, soft tissue, small-animal models, porous materials, composites, batteries, rocks, and manufactured components. As research increasingly needs quantitative, volumetric, and repeatable structural data, micro-CT is becoming a core analytical platform in academic, industrial, and pharmaceutical laboratories.

The market is evolving from standalone imaging instruments toward integrated imaging and analysis platforms. Vendors now pair hardware with automated workflows, advanced reconstruction algorithms, and quantitative analysis software. Progress in phase-contrast and spectral imaging, faster scanning, and AI-based denoising and reconstruction is widening the range of samples and research questions micro-CT can address, including low-contrast soft tissue, multi-material samples, and dynamic in-situ studies.

Market Dynamics

The micro computed tomography market is gaining momentum as research workflows increasingly depend on high-resolution 3D structural information. Growth is supported by rising biomedical and preclinical research activity, growing demand for non-destructive testing and characterization of advanced materials, heavy investment in battery and energy-storage R&D, and continuing improvements in system performance and usability.

Market Concentration & Characteristics

The micro-CT market is a specialized scientific-instrument industry in which system performance, application expertise, software, and service support influence purchasing decisions. Products are differentiated by spatial resolution, X-ray source and detector configuration, sample size, field of view, scanning speed, in-situ capabilities, spectral or phase-contrast functions, and the ability to integrate with analytical workflows. Product development often requires close interaction between instrument manufacturers and end users. Research institutions may require customized sample holders, environmental stages, specialized acquisition protocols, or analysis software. Industrial users may prioritize throughput, measurement repeatability, automation, and inspection of components with complex geometries. The market includes suppliers with broad scientific-instrument portfolios as well as companies focused on specialized micro-CT or X-ray microscopy systems. Competitive positioning should therefore be assessed by product capability and target application rather than by total company revenue alone.

To learn more about this report, Download Free Sample Report

The market is characterized by continuous innovation in X-ray sources, detectors, reconstruction algorithms, and automated analysis software. Key areas of development include sub-micron resolution, faster and lower-dose scanning, spectral and phase-contrast imaging for improved material and soft-tissue differentiation, and AI-driven workflows. Innovation is shifting from simply acquiring images toward delivering automated, quantitative, and reproducible insights. Some of the key innovations are:

• A resolution upgrade to Thermo Fisher’s HeliScan reduced the smallest achievable voxel from 800 nm to 400 nm

• Tescan’s UniTOM HR was introduced as the first dynamic micro-CT to combine sub-micron static imaging with 4D time-resolved capability

• In April 2026, North Star Imaging launched efX 3.0 CT visualization software, delivering a reimagined, project-based workflow for industrial X-ray and computed tomography (CT) visualization. Similarly, recently Glimpse launched Explore, a web-based industrial X-ray CT (computed tomography) viewer and sharing platform designed for hardware teams

Partnerships in the micro-CT market can involve instrument manufacturers, universities, national laboratories, research institutes, battery developers, materials manufacturers, pharmaceutical companies, and software developers. Collaborations may support the development of specialized imaging methods, testing protocols, sample environments, reconstruction algorithms, and application-specific workflows. Research facilities can provide manufacturers with access to demanding applications and early feedback on system performance. Industrial partners may support the development of methods for battery characterization, additive manufacturing, composites, or other complex materials. Software collaborations may focus on segmentation, AI-assisted reconstruction, quantitative analysis, and automated image processing.

Publicly funded research infrastructure also contributes to the development of specialized micro-CT capabilities. For example, the Australian Synchrotron's micro-computed tomography beamline provides micron-scale imaging and phase-contrast methods for research users.

The impact of regulations on micro computed tomography depends on their final application. Because micro-CT delivers high-resolution 3D imaging at the micrometer scale, systems are legally divided into preclinical/industrial applications (imaging small animals or materials) and clinical medical applications (imaging human patients, such as in dental or extremity scans). However, most systems are sold as research or industrial instruments rather than clinical devices, that ease the regulatory impact on the system. Radiation-safety rules, export and import requirements, and GLP-aligned workflows in pharmaceutical settings still shape system design and purchasing.

Micro-CT competes with or complements other imaging and characterization techniques depending on the sample and research question. Potential alternatives include conventional X-ray CT, microscopy, scanning electron microscopy, magnetic resonance imaging, ultrasound, optical imaging, destructive sectioning, and other non-destructive testing methods.

Conventional CT may be more suitable for larger objects or applications where micrometer-scale resolution is unnecessary. Microscopy can provide high-resolution surface or section-level information but may not reveal the full internal three-dimensional structure of an opaque sample without preparation or sectioning. Magnetic resonance and optical methods may be preferred for selected biological applications depending on tissue characteristics, contrast requirements, and study design.

Micro-CT's competitive position depends on its ability to deliver useful three-dimensional internal information at an appropriate resolution, sample size, acquisition time, and cost. In many workflows, it complements rather than fully replaces other methods.

Regional market development is influenced by investment in scientific research, university and laboratory infrastructure, industrial R&D, pharmaceutical and biotechnology activity, battery manufacturing, additive manufacturing, and access to advanced imaging systems. These include China’s HEPS, with 14 user beamlines in its first phase and space for at least 90. They also include South Korea’s Korea Light Source, which broke ground on July 27, 2026 with a KRW 1.1643 trillion budget. There is also Thailand’s Siam Photon Source II, a 3 GeV facility with seven Phase-1 beamlines,

Analyst Perspective

The micro computed tomography market has a positive outlook through 2033, with value shifting from standalone scanners toward integrated platforms that pair high-resolution hardware with AI-assisted reconstruction and automated analysis. Laboratory/benchtop systems and research institutes remain the base of demand, and biomedical and preclinical research remains the largest application. Growth is increasingly coming from faster-expanding areas: in-vivo imaging, pharma and biotech users, and energy and battery research, where micro-CT is moving from lab characterization into production-line inspection. North America leads on funding and vendor presence, while Asia Pacific is the fastest-growing region, supported by large EV and battery supply chains and new synchrotron and national R&D investment. High capital cost, limited access to advanced facilities, and growing competition from lower-cost regional vendors remain the main constraints. Players that combine strong hardware with software and serve both research and industrial users are best placed to gain share.

Product Insights

The laboratory / benchtop micro-CT segment dominated the market in 2025, accounting for approximately 52.2% of overall market revenue. Its leading position is primarily attributed to its smaller footprint, and lower cost than synchrotron-based alternatives. Institutions keep investing in this class, including the Rostock system above and the Institut de Recherche en Médecine de Montpellier’s installation of a NeoScan N80 for bone biology. Vendors are also pushing benchtop limits on sample size and speed, as with the SkyScan 1273, and on dynamic capability.

The in-vivo micro-CT segment is expected to witness fastest growth in the micro CT market over the forecast period. Growth is supported by rising preclinical research, increasing demand for longitudinal imaging of live small-animal models, and the need for reduced-dose, high-throughput systems in drug discovery and translational studies. Advances in low-dose protocols, respiratory and cardiac gating, and faster acquisition are improving image quality while limiting radiation exposure to the animal. Expanding use in oncology, musculoskeletal, and respiratory research is expected to further accelerate adoption.

Technology Insights

The spatial resolution segment dominated the market with a revenue share of 34.6% in 2025, supported by its high spatial resolution. The feature allows detailed visualization and quantification of fine structures such as trabecular bone, pores, fibers, and microcracks. Ongoing improvements in X-ray sources, detectors, and geometric magnification are pushing achievable resolution to sub-micron levels. This sustains strong demand from users who need precise structural and morphometric data.

The AI-assisted reconstruction segment is expected to witness the fastest growth over the forecast period. AI and deep-learning methods are being used to reduce noise and artifacts, enable high-quality reconstruction from fewer projections or lower doses, accelerate processing, and automate image segmentation and analysis. These capabilities improve throughput and reproducibility and make advanced imaging accessible to less specialized users. Their value is greatest where fast scanning, low-dose imaging, and large-volume analysis matter, such as in-vivo studies and high-throughput industrial and battery inspection. Growing vendor investment in software-driven differentiation is expected to support rapid adoption.

Application Insights

The biomedical & preclinical research segment dominated the market with a revenue share of 36.0% in 2025, supported by the established role of micro-CT in studying bone and musculoskeletal conditions, cardiovascular and pulmonary structures, tumor models, dental and implant research, and tissue engineering. Micro-CT provides quantitative, three-dimensional morphological data that supports disease modeling, therapeutic evaluation, and translational research. Strong academic funding, extensive use in core imaging facilities, and widespread adoption in small-animal studies continue to underpin the segment’s leadership.

The energy & battery research segment is expected to witness the fastest growth over the forecast period. Growth is driven by rapid expansion of battery development for electric vehicles and energy storage, and by the need to understand electrode microstructure, internal defects, swelling, and degradation mechanisms non-destructively. Micro-CT is increasingly used for quality control, failure analysis, and in-situ or operando studies of battery cells. Interest in next-generation chemistries such as solid-state batteries, along with fuel cell and hydrogen-related research, is expected to further strengthen demand.

End Use Insights

The research institutes segment dominated the market with a revenue share of 38.4% in 2025, supported by the large installed base of micro-CT systems in universities, government laboratories, and core facilities. These institutions use micro-CT across biomedical, materials, geological, and environmental studies, and benefit from public research funding and shared-instrumentation models. For instance, by February 2026, the Rostock and Wisconsin installations above. At the high end, HEPS had supported 222 proposals at 13 user beamlines with more than 700 users from 91 institutes. The breadth of applications and demand for versatile, high-resolution systems continue to make research institutes the primary buyers.

To learn more about this report, Download Free Sample Report

The pharma & biotech companies segment is expected to witness the fastest growth over the forecast period. Growth is supported by increasing use of micro-CT in preclinical drug discovery and development, particularly for evaluating efficacy and safety in musculoskeletal, oncology, respiratory, and metabolic models. Demand for higher throughput, reproducible quantitative endpoints, and in-house imaging capabilities is encouraging companies to invest in advanced and in-vivo systems. Greater use of imaging biomarkers and AI-enabled analysis within R&D pipelines is expected to reinforce this trend.

Regional Insights

North America accounted for the largest revenue share of 46.4% in 2025, supported by strong public and private research funding, a dense network of academic and research institutions, a large pharmaceutical and biotechnology sector, and the presence of leading micro-CT manufacturers. Industrial inspection is also expanding. North Star Imaging reported Nadcap accreditation for nondestructive testing at its California and Florida facilities in 2026. The U.S. is the main contributor, with extensive use of micro-CT in biomedical, materials, and energy research, and is expected to grow significantly over the forecast period.

To learn more about this report, Download Free Sample Report

U.S. Micro Computed Tomography Market Trends

The market in theU.S.held the largest share in the north america region in 2025 andis experiencing strong growth due to the APS upgrade and a dense network of vendors and core facilities. The APS upgrade’s brightness gains mean imaging tasks that took hours can now be done in minutes. Recent activity includes the Tescan Warrendale demo lab, Revvity’s Waltham-based preclinical imaging portfolio, and new core-facility purchases such as Wisconsin’s N80.

Europe Micro Computed Tomography Market Trends

The Europe micro CT market is supported by a large bone-health burden (see the IOF projections above), strong battery-manufacturing ambitions, and world-class light sources. European EV sales grew by more than 30% in 2025, the strongest growth among major markets. Facility roadmaps are shaping access. Diamond-II is backed by £519 million of funding, and PETRA IV carries estimated construction costs of about €1.8 billion, with first light expected from 2032.

The U.K. micro CT market is supported by a world-class academic research base, strong life-science and pharmaceutical R&D, and access to national synchrotron and imaging facilities. Demand comes from preclinical research, orthopedics and dental research, materials science, and advanced manufacturing. Government and charity research funding and shared-facility models encourage the use of advanced systems. Growing interest in battery and energy research is also adding to demand.

The Germany micro CT market is characterized by a strong industrial base in automotive, aerospace, and precision engineering, and by a well-funded research sector. Industrial inspection, materials characterization, and additive-manufacturing quality control are important demand drivers alongside biomedical research. The presence of leading imaging and X-ray technology companies and research organizations supports innovation and local availability. Growing battery and electric-vehicle research is expected to strengthen demand for high-resolution and high-speed systems.

The Spain micro CT marketis benefiting from expanding research infrastructure, access to national synchrotron facilities, and growing biomedical and materials research. Public research centers and universities are the main buyers, with applications spanning life sciences, paleontology, geoscience, and industrial materials. Funding variability and regional budget differences influence adoption. Increasing industrial R&D and energy-related research are expected to support gradual market growth.

Asia Pacific Micro Computed Tomography Market Trends

The Asia-Pacific micro computed tomography market is expected to represent the fastest-growing regional markets, supported by rising research and development investment, expanding academic and pharmaceutical research infrastructure, and rapid growth in battery manufacturing, electronics, and advanced materials. China, Japan, South Korea, and India are key contributors, with growing local manufacturing and increasing domestic participation in the micro-CT supply landscape. Government support for scientific research and healthcare innovation is also expanding the installed base.

China's micro CT market is expected to grow rapidly, supported by large government investment in scientific research, a rapidly expanding battery and electric-vehicle industry, and growing biomedical and pharmaceutical R&D. The presence of domestic micro-CT manufacturers and growing localization of advanced instruments improve affordability and availability. Demand is rising in battery and materials inspection, semiconductor and electronics analysis, and preclinical research. The country’s expanding synchrotron and large-facility infrastructure further supports advanced imaging.

Japan's micro CT market is supported by a highly developed research ecosystem, a strong materials, electronics, and automotive industry, and advanced synchrotron infrastructure. The market places strong emphasis on accuracy, reliability, and quality. Key applications include materials and battery research, biomedical and dental studies, and industrial inspection. An aging population and a focus on musculoskeletal and regenerative research support demand for bone-focused micro-CT.

Latin America Micro Computed Tomography Market Trends

The Latin America micro CT marketis expected to expand gradually as research infrastructure develops and academic and industrial imaging capabilities grow. Brazil and Mexico are the main markets. Adoption is influenced by funding constraints and import costs, but increasing collaboration with international institutions and growing use in life sciences and geological research are supporting demand.

Brazil's micro CT market is supported by a strong public research system, a large university network, and advanced national synchrotron infrastructure. Applications include biomedical and dental research, geological and petroleum-related core analysis, and agricultural and materials research. Currency volatility and import costs can affect purchasing, but the country’s strong science base and growing industrial and energy research are expected to support continued growth.

Middle East & Africa Micro Computed Tomography Market Trends

The Middle East & Africa (MEA) micro CT marketis influenced by investment in universities, scientific research facilities, industrial laboratories, and specialized healthcare or biotechnology research. Saudi Arabia and the UAE are relevant markets to assess for research infrastructure and investment in advanced scientific equipment, while Kuwait and South Africa contribute through their research and industrial ecosystems.

The Saudi Arabia micro CT market is supported by a large government investment in research, higher education, and diversification under national development programs. Demand is emerging in petroleum and geoscience research, materials and energy research, and biomedical studies at leading research universities. Investment in advanced research infrastructure is expected to increase the installed base, though the market remains dependent on imports and international technical support.

Key Micro Computed Tomography Company Insights

The micro computed tomography market is moderately competitive, that includes manufacturers of micro-CT systems, high-resolution X-ray microscopy platforms, preclinical imaging systems, and specialized industrial or research imaging solutions. Competition is influenced by spatial resolution, sample capacity, image quality, scanning speed, system footprint, software capabilities, application support, and service coverage.

Key Micro Computed Tomography Companies

The following key companies have been profiled for this study on the micro computed tomography market.

• Bruker Corporation

• PerkinElmer Inc.

• Thermo Fisher Scientific

• Zeiss

• NeoScan

• Sanying Precision Instruments Co.Ltd

• North Star Imaging Inc

• SCANCO Medical AG

• TESCAN

Recent Development:

• In October 2026, Xavier University acquired a new micro-CT (micro-computed tomography) scanner, a transformational research tool rarely found at undergraduate teaching institutions. In the announcement from university the Assistant Professor of Biology and 2013 Xavier alumnus Tyler Imfeld, Ph.D said

“To have this kind of infrastructure at a small, teaching-focused institution like Xavier ... it's transformative in ways that I don't think have all been realized just yet.”

– Assistant Professor of Biology and 2013 Xavier alumnus Tyler Imfeld, Ph.D.

• In July 2026, Fraunhofer EZRT’s RoboCT, a robot-based micro-CT system for large and complex components, was featured as a way to bring large-scale CT out of the lab and into production-adjacent inspection.

Global Micro Computed Tomography Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global micro computed tomography market report based on product, technology, application, end use and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Laboratory / Benchtop Micro-CT

  • High-Resolution Micro-CT

  • In-vivo Micro-CT

  • Synchrotron-Based Micro-CT

  • Beamline Micro-CT Systems

• Technology Outlook (Revenue, USD Million, 2021 - 2033)

  • Spatial Resolution

  • Phase-Contrast Imaging

  • Spectral / Multi-Energy Imaging

  • High-Speed Scanning

  • AI-Assisted Reconstruction

  • Others

• Application Outlook (Revenue, USD Million, 2021 - 2033)

  • Biomedical & Preclinical Research

  • Materials & Industrial Research

  • Energy & Battery Research

  • Pharmaceutical Research

  • Geological & Environmental Research

  • Others

• End Use Outlook (Revenue, USD Million, 2021 - 2033)

  • Research Institutes

  • Pharma & Biotech Companies

  • Diagnostic Imaging Labs

  • Others

• Region Outlook (Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • China

    • Japan

    • South Korea

    • India

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • Saudi Arabia

    • South Africa

    • UAE

    • Kuwait

Research Methodology

The micro computed tomography marketfigures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each micro computed tomography segment quantified using the revenue-capture definitions in the table below.